Biotech

All Articles

Lilly, Haya ink $1B biobuck weight problems contract to search black genome

.Eli Lilly's search for being overweight intendeds has actually led it to the dark genome. The Big P...

ArsenalBio increases $325M, turns away from former lead resource

.Arsenal Biosciences is moving on up. The tissue therapy provider has actually added on $325 thousan...

Lilly- backed weight management biotech data IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually s...

Aelis' marijuana make use of medicine fails stage 2b, driving Indivior to review $100M alternative

.Aelis Farma's chances of protecting a fast, positive choice on a $one hundred thousand alternative ...

ProKidney standstills period 3 test certainly not needed for tissue therapy authorization

.ProKidney has actually ceased one of a set of stage 3 tests for its own cell therapy for renal dise...

Vaxcyte surges on 'impressive' 31-valent PCV win versus Pfizer

.Vaxcyte introduced what professionals called "magnificent" phase 1/2 information for its own 31-val...

Recursion's mind disease test presents little proof of efficacy

.Recursion has discovered through an early examination of its own tech-enabled approach to medicine ...

Acepodia, Pfizer click on with each other for chemistry-based cell treatment

.Call it an instance of great chemical make up: Acepodia, a biotech based on Nobel Prize-winning sci...

Praxis epilepsy medication lessens confiscations in stage 2 litigation

.Practice Preciseness Medicines has actually racked up another midphase win in epilepsy this year, w...

Three officers resign as Dyne blog posts combined information for DMD prospect

.After leaving a clinical hold many years back, Dyne Rehab has actually uncovered new phase 1/2 data...